← Eichor
Study identifier: NCT06737666 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome

Condition: Diarrhea-predominant Irritable Bowel Syndrome  ·  Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

PhasePhase 1
Planned participants60
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersYes

About this study

Traditional Chinese Medicine focuses on the main pathogenesis of liver depression and spleen deficiency, and treats them from the perspective of soothing the liver and strengthening the spleen to treat on Diarrhea-predominant irritable bowel syndrome (IBS-D) . The classic formula for treating is the Tong-Xie-Yao-Fang (TXYF). Based on metabolomics and metagenomics, the research group studied the intestinal flora and host co metabolism of TXYF in the treatment of diarrhea predominant IBS-D, in order to clarify the mechanism of TXYF in the treatment of IBS-D.

This description comes directly from the study's public registry record.

Talk to the study team

Fengyun Wang, professor  ·  +86 (010)-62835610  ·  wfy811@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Xiyuan Hospital of China Academy of Chinese Medical SciencesBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06737666